Search Results for: IT-27

ALPPL2 is a highly specific and targetable tumor cell surface antigen

Su Y, Zhang X, Bidlingmaier S, Behrens CR, Lee NK, Liu B (2020) ALPPL2 is a highly specific and targetable tumor cell surface antigen. Cancer Res 80(20):4552-4564. doi: 10.1158/0008-5472.CAN-20-1418 PMID: 32868383 Objective: To evaluate therapeutic potential of ALPPL2 targeting. Summary: Exquisite tissue specificity and broad tumor type coverage suggest that ALPPL2 could be an excellent […]

ALPPL2 is a highly specific and targetable tumor cell surface antigen Read More »

Murine HSCs contribute actively to native hematopoiesis but with reduced differentiation capacity upon aging

Säwen P, Eldeeb M, Erlandsson E, Kristiansen TA, Laterza C, Kokaia Z, Karlsson G, Yuan J, Soneji S, Mandal PK, Rossi DJ, Bryder D (2018) Murine HSCs contribute actively to native hematopoiesis but with reduced differentiation capacity upon aging. Elife 7:e41258. doi: 10.7554/elife.41258 PMID: 30561324 Related Products: Streptavidin-ZAP (Cat. #IT-27)

Murine HSCs contribute actively to native hematopoiesis but with reduced differentiation capacity upon aging Read More »

Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells

Facciabene A, Peng X, Hagemann IS, Balint K, Barchetti A, Wang L-P, Gimotty PA, Gilks CB, Lal P, Zhang L, Coukos G (2011) Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells. Nature 475:226-230. doi: 10.1038/nature10169 PMID: 21753853 Objective: To investigate whether a direct link between tumor hypoxia and tolerance occurs through the

Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells Read More »

Shopping Cart
Scroll to Top